Stereotactic Ablative Radiotherapy (SABR)

What is SABR?

We are pleased to be able to offer an advanced and effective new private radiotherapy service for the treatment of lung metastases – Stereotactic Ablative Radiotherapy (SABR).

SABR is a non-invasive advanced radiotherapy technique that delivers an ablative dose of radiation over a small number of outpatient treatment sessions (typically 3 – 8), with the aim of improving tumour control and reducing side effects to other tissues.

SABR is:

  • widely used for the treatment of lung metastases in North America, Europe and Asia
  • has proven high rates of local tumour control (>90%)
  • typically very low rates of side effects.
  • In the UK, SABR is now being used to treat patients with oligometastatic disease
  • SABR can be used to treat 1-3 lung metastases in patients who have a good prognosis from their primary cancer.

SABR treatment at Nova Healthcare

The service is led by Dr Kevin Franks and Dr Peter Dickinson, Consultant Clinical Oncologists at the St James’s Institute of Oncology.

Dr Kevin Franks is one of the leading SABR clinicians in the UK, having completed a SABR Research Fellowship at the Princess Margaret Hospital in Toronto prior to his appointment as a consultant in Leeds.

Dr Peter Dickinson is a key member of the Leeds Lung SABR team and will be leading the Leeds Lung Oligometastatic SABR programme. He completed a technical radiotherapy research fellowship at the Christie Hospital in Manchester prior to his consultant post in Leeds.

Download referral criteria

At Nova we offer SABR treatment for patients with the following cancers and conditions:

At Nova Healthcare, we’re with you every step of the way 

Receiving care at Nova means you will have a dedicated team of experts with you every step of the way, looking after your physical and emotional wellbeing. Find out more about the care we provide at Nova and our values here.

Book now

If you have any questions or would like to book an appointment, contact us or call us on 0113 206 7503.